home / stock / prn:cc / prn:cc news

PRN:CC News and Press, Profound Medical Corp. From 03/04/24

Stock Information
Company Name: Profound Medical Corp.
Stock Symbol: PRN:CC
Market: TSXC
Website: profoundmedical.com
Menu
PRN:CC PRN:CC Quote PRN:CC Short PRN:CC News PRN:CC Articles PRN:CC Message Board
Get PRN:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
PRN:CC - Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference

TORONTO, March 04, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, t...
PRN:CC - Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure

TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, to...

PRN:CC - Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 - Conference Call to Follow

TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, wi...

PRN:CC - Profound Medical announces $2.94M non-brokered private placement

2024-01-16 16:35:19 ET More on Profound Medical Profound Medical lays out Q4 and FY 2024 preliminary numbers Profound Medical sells 2.67M shares at $7.50 in public offering For further details see: Profound Medical announces $2.94M non-brokered private placement
PRN:CC - Profound Medical Announces Non-Brokered Private Placement

TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (" Profound " or the " Company ") is pleased to announce that the Company has entered into subscription agreements, dated as of January 16, 2024, with certain existing Canadian institutional investors...

PRN:CC - Profound Medical lays out Q4 and FY 2024 preliminary numbers

2024-01-04 03:31:30 ET More on Profound Medical Profound Medical sells 2.67M shares at $7.50 in public offering Biggest stock movers today: Sociedad Quimica Y Minera de Chile, Profound Medical and more Seeking Alpha’s Quant Rating on Profound Medical F...

PRN:CC - Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues

TORONTO, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, to...
PRN:CC - Profound Medical sells 2.67M shares at $7.50 in public offering

2023-12-28 09:54:35 ET More on Profound Medical Profound Medical Corp. (PROF) Q3 2023 Earnings Call Transcript Biggest stock movers today: Sociedad Quimica Y Minera de Chile, Profound Medical and more Profound Medical stock sinks on proposed public offering of common...

PRN:CC - Marathon Digital, Hut 8, AEye among premarket losers' pack

2023-12-28 08:51:19 ET Bluejay Diagnostics ( BJDX ) -36% on pricing of $3.5 million stock offering . Cytosorbents CTSO -29% as blood purification system fails key trial . First Wave BioPharma ( FWBI ) -17% . NKGen Biotech ( NKGN ) -12% . ...

PRN:CC - Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares

TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“ Profound ” or the “ Company ”) today announced the pricing of its previously announced underwritten public offering (the “ Offering ”) of 2,666,667 com...
Previous 10 Next 10